Early Experience Using a Left Atrial Appendage Occlusion Device in Patients with Atrial Fibrillation

PURPOSE: Atrial fibrillation (AF) is one of the major risk factors for ischemic stroke, and 90% of thromboembolisms in these patients arise from the left atrial appendage (LAA). Recently, it has been documented that an LAA occlusion device (OD) is not inferior to warfarin therapy, and that it reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yung Ly, Joung, Boyoung, On, Young Keun, Shim, Chi Young, Lee, Moon Hyoung, Kim, Young-Hoon, Pak, Hui-Nam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250321/
https://www.ncbi.nlm.nih.gov/pubmed/22187236
http://dx.doi.org/10.3349/ymj.2012.53.1.83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250321/
https://www.ncbi.nlm.nih.gov/pubmed/22187236
http://dx.doi.org/10.3349/ymj.2012.53.1.83

Ejemplares similares